Cigna Less: Receipts on loans receivable decreased by 92.0% to $2.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 97.6%, from $85.00M to $2.00M. Over 4 years (FY 2021 to FY 2025), Less: Receipts on loans receivable shows an upward trend with a 5.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher collections indicate effective credit management and liquidity recovery from lending activities.
This reflects cash received from the repayment of principal on loans extended by the company to third parties. It indica...
Relevant for companies with significant lending or mortgage-related investment segments.
investing_proceeds_from_collection_of_loans_receivable| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $24.00M | $31.00M | $53.00M | $65.00M | $4.00M | $4.00M | $25.00M | $4.00M | $78.00M | $4.00M | $100.00M | $4.00M | $33.00M | $42.00M | $109.00M | $85.00M | $5.00M | $108.00M | $25.00M | $2.00M |
| QoQ Change | — | +29.2% | +71.0% | +22.6% | -93.8% | +0.0% | +525.0% | -84.0% | >999% | -94.9% | >999% | -96.0% | +725.0% | +27.3% | +159.5% | -22.0% | -94.1% | >999% | -76.9% | -92.0% |
| YoY Change | — | — | — | — | -83.3% | -87.1% | -52.8% | -93.8% | >999% | +0.0% | +300.0% | +0.0% | -57.7% | +950.0% | +9.0% | >999% | -84.8% | +157.1% | -77.1% | -97.6% |